BridgeBio Pharma Grants 83,283 Inducement Shares to 37 New Hires

GlobeNewswire··Read original
1▲0 ▼0Impact / 5
Summary · why it matters

BridgeBio Pharma announced that its compensation committee approved equity grants to 37 new employees, totaling 83,283 restricted stock units. The awards were granted as inducements material to the employees entering employment, in accordance with Nasdaq Listing Rule 5635(c)(4). One-fourth of the shares underlying each award will vest on August 16, 2027, with the remainder vesting quarterly thereafter, subject to continued employment.

Impact on assets 1

Biotech & Genomic Medicine▲
BridgeBio Pharma Inc
BBIO
± MixedCapitalrelevance

Equity grants to new hires are standard inducement, not material to business performance.